IL22 and colorectal carcinoma: In human CRC, both T cell and non-T cell (lineage-negative) sources of IL-22 have been observed [116, 117]; however, in a model of bacteria-driven colitis-associated cancer (CAC) colonic ILC3 were sufficient for the development of invasive tumors [116].